Antares Vision opens R&D centre in Ireland

Crest Solutions is delighted to announce that our key partner Antares Vision is opening an R&D centre in Ireland. 

Tackling counterfeit medicine

In 2013, Antares Vision, Crest Solutions and our sister company VistaLink joined forces as key partners.

Our objective was to deliver the leading range of Antares Vision serialisation solutions to pharmaceutical sites in Ireland, the UK, Benelux and Scandinavia, assisting to tackle the global issue of counterfeit medicines. 

Leading innovations from an Irish base

Now, 4 years on, we are delighted to announce that Antares Vision is making further commitment to the quality of supply chains globally and have selected Ireland as the home for their new Research & Development centre. 

Collaborating to create impact

The world of inspection, product quality and traceability is changing every day.

Through partnering and collaboration, leading minds like those on the teams in Antares Vision, VistaLink and Crest Solutions are creating real products and solutions that secure supply chains and consumers worldwide.

We are delighted to welcome Antares Vision to Ireland. Not only will the move create over 50 jobs, it also marks an exciting development for inspection technologies and regulated industry in Europe as it allows for even greater alignment in our innovation of leading technologies. 

Ultimately, the quality of consumer products is becoming more secure and the influx of dangerous, counterfeit products is being curbed more and more, day by day. 

Crest Solutions and VistaLink continue to support clients leveraging Antares Vision solutions in Ireland, the UK, Benelux and Scandiavia.

Related:

https://www.irishtimes.com/business/economy/two-tech-companies-plan-to-create-over-100-jobs-in-ireland-1.3318753
https://www.rte.ie/news/business/2017/1207/925611-cork-and-galway-jobs/
https://irishtechnews.ie/antares-vision-to-establish-a-software-development-centre-in-galway-creating-53-jobs/
www.antaresvision.com
www.vistalink.be

Share This